You are here:    Home For Scientists Drug Discovery Initiative NF Preclinical Consortium

Question and Answer with Dr. Kim

ja_mageia

DDI NF Preclinical Consortium PDF Print E-mail

The NF Preclinical Consortium is a $4M investment of the Childrens Tumor Foundation.

A multi-site collaboration of six research Centers, each focused on different tumor manifestations of NF1 and NF2,
the Centers of the Consortium began working together in 2008.

They are testing candidate NF drugs in parallel in multiple NF tumor models.

Industry collaborators to date include Novartis, Genetech and Avila Therapeutics.

 

NF Preclinical Consortium Centers 
University of California, San Francisco
Director: Kevin Shannon, MD, Ph.D.
Tumor Focus:  NF1 myeloid leukemia

Washington University School of Medicine
Director: David Gutmann, MD, Ph.D.
Tumor Focus:  NF1 optic pathway glioma          

Cincinnati Children’s Hospital Medical Center
Director: Timothy Cripe, MD, Ph.D.
Deputy Director: Nancy Ratner, Ph.D.
Tumor Focus: NF1 plexiform tumors & dermal neurofibromas

House Ear Institute
Director: Marco Giovannini, MD, Ph.D.
Tumor Focus: NF2 schwannoma, meningioma
                                                                                                                                                                                                                           
Harvard Med School/Mass General Hospital
Director: Andrea McClatchey, Ph.D.

Tumor Focus: NF2 schwannoma, meningioma   

Harvard Medical School/Brigham & Women’s Hospital
Director: Karen Cichowski, Ph.D.                   
Deputy Directors: Thomas De Raedt, Ph.D. & Ophelia Maertens, Ph.D.
Tumor Focus: NF1 malignant peripheral
nerve sheath tumors     

 

NF Preclinical Consortium External Advisory Board (EAB)
 

Jay Gibbs, Ph.D. (Chair), AstraZeneca Pharmaceuticals

Gideon E. Bollag, Ph.D., Plexxikon Inc.

Sara A. Courtneidge, Ph.D. , The Burnham Inst. for Medical Research

Michael J. Morin, Ph.D., Oncovia, Inc.

Frank McCormick, Ph.D., University of California, San Francisco

Edward Stern, Esq.,  Legal Counel to the CTF Medical Advisory Committee

 

EAB Emeritus Members

Larry Gelbert, Ph.D., Eli Lilly and Company 

Filippo G. Giancotti, M.D., Ph.D. Memorial Sloan-Kettering Cancer Center

Janet M Hock, BDS, Ph.D., Maine Institute for Human Genetics and Health

Christopher L. Moertel, MD, Children's Hospitals and Clinics of Minnesota

Roger J. Packer, MD, Children’s National Medical Center


Questions? Contact:
Kim Hunter-Schaedle, Ph.D., Chief Scientific Officer
This e-mail address is being protected from spambots. You need JavaScript enabled to view it


 

 

Upcoming Events

Sat Sep 11, 2010 @10:00am -
Wisconsin: Milwaukee NF Walk
Sun Sep 12, 2010 @ 2:00pm -
Colorado: Denver NF Walk
Thu Sep 16, 2010 @ 8:00pm - 11:00pm
Arkansas: Dancing With Our Stars
Fri Sep 17, 2010 @ 7:30pm - 11:30pm
New York: Gracie's Gang WANTED: A CURE
Sat Sep 18, 2010 @ 8:30am -
Maine: Brunswick NF Walk
Sat Sep 25, 2010 @ 8:30am -
New York: Staten Island NF Walk